Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot Study
Clinical trial NCT07297602 · RECRUITING
Trial details
- NCT number
- NCT07297602
- Sponsor
- Nora Mohamed Abdelrazik
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-20
- Primary completion
- 2026-05-20
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.